For example, injection of syngeneic pancreatic adenocarcinoma cells in the pancreas resulted in enhanced tumor growth compared to subcutaneous sites and differential expression of the tumor antigen Muc1 [30]. This evidence concerns the gene MUC1 and pancreatic adenocarcinoma.